3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-

Request For Quotation

3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- manufacturers

  • BCR-ABL-IN-4
  • BCR-ABL-IN-4 pictures
  • $1980.00
  • 2026-07-27
  • CAS:2669790-59-2
  • Purity:
  • Supply Ability: 10g
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- Basic information
Product Name:3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-
Synonyms:3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-;BCR-ABL-IN-4
CAS:2669790-59-2
MF:C27H24ClF2N5O4
MW:555.96
EINECS:
Product Categories:
Mol File:2669790-59-2.mol
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- Structure
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- Chemical Properties
Boiling point 717.5±60.0 °C(Predicted)
density 1.538±0.06 g/cm3(Predicted)
pka10.77±0.70(Predicted)
Safety Information
MSDS Information
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- Usage And Synthesis
UsesBCR-ABL-IN-4 is a BCR-ABL inhibitor with anticancer effects. BCR-ABL-IN-4 inhibits the cancer cell growth with IC50 values of 0.67 nM and 16 nM for K562 cells and BCR-ABL T315I transfected Ba/F3 cells, respectively (WO2021143927A1; compound 11)[1].
References[1] Yinsheng Zhang, et al. Compound acting as bcr-abl inhibitor. WO2021143927A1.
3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]- Preparation Products And Raw materials
Tag:3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-5-(6-cyclopropyl-6,7-dihydro-5-oxo-5H-pyrrolo[3,4-b]pyridin-3-yl)-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-(2669790-59-2) Related Product Information
AST 487 Ponatinib PD 166326 Flumatinib Asciminib NOCODAZOLE